RhumbLine Advisers’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $86.5M | Buy |
|
|||||
|
2025
Q2 | $85.7M | Sell |
|
|||||
|
2025
Q1 | $81.9M | Buy |
|
|||||
|
2024
Q4 | $80.4M | Sell |
|
|||||
|
2024
Q3 | $74.1M | Sell |
|
|||||
|
2024
Q2 | $110M | Sell |
|
|||||
|
2024
Q1 | $118M | Buy |
|
|||||
|
2023
Q4 | $93.9M | Sell |
|
|||||
|
2023
Q3 | $85.8M | Sell |
|
|||||
|
2023
Q2 | $118M | Buy |
|
|||||
|
2023
Q1 | $103M | Buy |
|
|||||
|
2022
Q4 | $88.1M | Buy |
|
|||||
|
2022
Q3 | $94.9M | Buy |
|
|||||
|
2022
Q2 | $107M | Buy |
|
|||||
|
2022
Q1 | $130M | Buy |
|
|||||
|
2021
Q4 | $140M | Sell |
|
|||||
|
2021
Q3 | $122M | Sell |
|
|||||
|
2021
Q2 | $113M | Sell |
|
|||||
|
2021
Q1 | $96.1M | Sell |
|
|||||
|
2020
Q4 | $110M | Sell |
|
|||||
|
2020
Q3 | $96.5M | Buy |
|
|||||
|
2020
Q2 | $83.2M | Sell |
|
|||||
|
2020
Q1 | $78.5M | Buy |
|
|||||
|
2019
Q4 | $94.7M | Buy |
|
|||||
|
2019
Q3 | $84.3M | Buy |
|
|||||
|
2019
Q2 | $70.2M | Buy |
|
|||||
|
2019
Q1 | $71.6M | Sell |
|
|||||
|
2018
Q4 | $58.6M | Sell |
|
|||||
|
2018
Q3 | $69.4M | Sell |
|
|||||
|
2018
Q2 | $59.5M | Buy |
|
|||||
|
2018
Q1 | $55M | Sell |
|
|||||
|
2017
Q4 | $45.6M | Buy |
|
|||||
|
2017
Q3 | $43M | Sell |
|
|||||
|
2017
Q2 | $47.1M | Sell |
|
|||||
|
2017
Q1 | $37.8M | Buy |
|
|||||
|
2016
Q4 | $37.2M | Buy |
|
|||||
|
2016
Q3 | $45.4M | Buy |
|
|||||
|
2016
Q2 | $36.8M | Buy |
|
|||||
|
2016
Q1 | $31.4M | Buy |
|
|||||
|
2015
Q4 | $26.9M | Buy |
|
|||||
|
2015
Q3 | $23.9M | Buy |
|
|||||
|
2015
Q2 | $23.9M | Buy |
|
|||||
|
2015
Q1 | $21.9M | Buy |
|
|||||
|
2014
Q4 | $19.6M | Sell |
|
|||||
|
2014
Q3 | $16.2M | Sell |
|
|||||
|
2014
Q2 | $13.6M | Sell |
|
|||||
|
2014
Q1 | $12.7M | Sell |
|
|||||
|
2013
Q4 | $11.7M | Sell |
|
|||||
|
2013
Q3 | $13.5M | Sell |
|
|||||
|
2013
Q2 | $13M | Buy |
|